CTi Biopharma Corp Price History
CTICDelisted Stock | USD 9.09 0.00 0.00% |
If you're considering investing in CTi Stock, it is important to understand the factors that can impact its price. As of today, the current price of CTi Biopharma stands at 9.09, as last reported on the 18th of April 2024, with the highest price reaching 9.09 and the lowest price hitting 9.09 during the day. We have found twenty-five technical indicators for CTi Biopharma Corp, which you can use to evaluate the volatility of the firm. Please confirm CTi Biopharma's Risk Adjusted Performance of 0.0985, downside deviation of 2.35, and Mean Deviation of 3.53 to double-check if the risk estimate we provide is consistent with the expected return of 0.0%.
CTi Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
CTi |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
CTIC |
Based on monthly moving average CTi Biopharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CTi Biopharma by adding CTi Biopharma to a well-diversified portfolio.
CTi Biopharma Stock Price History Chart
There are several ways to analyze CTi Stock price data. The simplest method is using a basic CTi candlestick price chart, which shows CTi Biopharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
CTi Stock Price History Data
The price series of CTi Biopharma for the period between Fri, Jan 19, 2024 and Thu, Apr 18, 2024 has a statistical range of 5.02 with a coefficient of variation of 33.23. The prices are distributed with arithmetic mean of 6.74. The median price for the last 90 days is 5.3. The company had 1:10 stock split on 3rd of January 2017. CTi Biopharma Corp issued dividends on 2017-01-03.Open | High | Low | Close | Volume | ||
04/18/2024 | 9.09 | 9.09 | 9.09 | 9.09 | ||
06/26/2023 | 9.09 | 9.09 | 9.09 | 9.09 | 1.00 | |
06/23/2023 | 9.10 | 9.10 | 9.09 | 9.09 | 11,387,827 | |
06/22/2023 | 9.09 | 9.10 | 9.09 | 9.09 | 1,890,480 | |
06/21/2023 | 9.09 | 9.10 | 9.08 | 9.10 | 4,836,839 | |
06/20/2023 | 9.07 | 9.09 | 9.07 | 9.09 | 3,907,143 | |
06/16/2023 | 9.08 | 9.08 | 9.07 | 9.07 | 8,572,264 | |
06/15/2023 | 9.07 | 9.08 | 9.07 | 9.07 | 1,496,068 | |
06/14/2023 | 9.07 | 9.08 | 9.07 | 9.07 | 1,824,245 | |
06/13/2023 | 9.07 | 9.08 | 9.07 | 9.08 | 4,708,600 | |
06/12/2023 | 9.07 | 9.08 | 9.07 | 9.08 | 2,291,469 | |
06/09/2023 | 9.05 | 9.06 | 9.04 | 9.05 | 1,155,910 | |
06/08/2023 | 9.04 | 9.05 | 9.03 | 9.05 | 2,194,849 | |
06/07/2023 | 9.05 | 9.05 | 9.04 | 9.04 | 1,509,958 | |
06/06/2023 | 9.04 | 9.05 | 9.04 | 9.05 | 1,725,134 | |
06/05/2023 | 9.04 | 9.05 | 9.04 | 9.05 | 2,841,661 | |
06/02/2023 | 9.05 | 9.06 | 9.04 | 9.05 | 1,948,101 | |
06/01/2023 | 9.04 | 9.05 | 9.03 | 9.05 | 1,755,630 | |
05/31/2023 | 9.04 | 9.05 | 9.02 | 9.05 | 2,855,218 | |
05/30/2023 | 9.03 | 9.04 | 9.02 | 9.02 | 1,643,574 | |
05/26/2023 | 9.02 | 9.05 | 9.01 | 9.05 | 3,489,274 | |
05/25/2023 | 9.02 | 9.03 | 9.01 | 9.02 | 2,575,883 | |
05/24/2023 | 8.98 | 9.02 | 8.98 | 9.00 | 3,372,159 | |
05/23/2023 | 8.97 | 9.05 | 8.97 | 8.99 | 5,150,481 | |
05/22/2023 | 8.93 | 8.95 | 8.93 | 8.93 | 3,806,582 | |
05/19/2023 | 8.93 | 8.94 | 8.92 | 8.94 | 3,142,502 | |
05/18/2023 | 8.92 | 8.93 | 8.92 | 8.92 | 2,934,490 | |
05/17/2023 | 8.92 | 8.94 | 8.91 | 8.93 | 7,618,462 | |
05/16/2023 | 8.89 | 8.93 | 8.87 | 8.91 | 8,432,443 | |
05/15/2023 | 8.94 | 8.96 | 8.92 | 8.93 | 9,783,117 | |
05/12/2023 | 8.92 | 8.96 | 8.92 | 8.96 | 14,639,857 | |
05/11/2023 | 8.91 | 8.95 | 8.91 | 8.94 | 13,882,341 | |
05/10/2023 | 8.91 | 8.93 | 8.90 | 8.93 | 126,373,417 | |
05/09/2023 | 4.79 | 4.89 | 4.74 | 4.82 | 1,714,591 | |
05/08/2023 | 4.91 | 5.00 | 4.80 | 4.82 | 1,510,525 | |
05/05/2023 | 5.05 | 5.10 | 4.86 | 4.90 | 2,915,123 | |
05/04/2023 | 5.13 | 5.16 | 4.99 | 4.99 | 1,897,072 | |
05/03/2023 | 4.98 | 5.19 | 4.94 | 5.17 | 2,592,992 | |
05/02/2023 | 4.87 | 5.00 | 4.81 | 4.91 | 2,172,948 | |
05/01/2023 | 4.82 | 4.99 | 4.82 | 4.89 | 1,633,227 | |
04/28/2023 | 4.77 | 4.93 | 4.70 | 4.86 | 2,541,455 | |
04/27/2023 | 4.95 | 4.97 | 4.69 | 4.79 | 3,789,636 | |
04/26/2023 | 5.01 | 5.07 | 4.74 | 4.94 | 3,243,224 | |
04/25/2023 | 5.10 | 5.17 | 4.94 | 5.02 | 1,777,844 | |
04/24/2023 | 5.27 | 5.30 | 4.95 | 5.11 | 2,500,111 | |
04/21/2023 | 5.02 | 5.39 | 4.97 | 5.30 | 3,876,719 | |
04/20/2023 | 5.05 | 5.15 | 4.97 | 5.03 | 3,856,570 | |
04/19/2023 | 4.42 | 5.20 | 4.42 | 5.12 | 9,230,705 | |
04/18/2023 | 4.41 | 4.55 | 4.29 | 4.48 | 3,070,954 | |
04/17/2023 | 4.27 | 4.48 | 4.21 | 4.40 | 3,291,978 | |
04/14/2023 | 4.36 | 4.37 | 4.20 | 4.26 | 1,395,254 | |
04/13/2023 | 4.26 | 4.42 | 4.25 | 4.39 | 2,925,769 | |
04/12/2023 | 4.42 | 4.51 | 4.21 | 4.22 | 2,327,432 | |
04/11/2023 | 4.27 | 4.42 | 4.23 | 4.39 | 1,926,605 | |
04/10/2023 | 4.17 | 4.32 | 4.16 | 4.26 | 2,130,181 | |
04/06/2023 | 4.09 | 4.33 | 4.01 | 4.23 | 3,713,566 | |
04/05/2023 | 4.08 | 4.19 | 4.06 | 4.08 | 1,748,470 | |
04/04/2023 | 4.30 | 4.30 | 4.08 | 4.09 | 2,446,720 | |
04/03/2023 | 4.21 | 4.40 | 4.21 | 4.30 | 2,547,188 | |
03/31/2023 | 4.32 | 4.33 | 4.16 | 4.20 | 3,309,768 | |
03/30/2023 | 4.43 | 4.49 | 4.15 | 4.28 | 2,923,439 |
About CTi Biopharma Stock history
CTi Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for CTi is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in CTi Biopharma Corp will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing CTi Biopharma stock prices may prove useful in developing a viable investing in CTi Biopharma
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. CTI BioPharma Corp. was incorporated in 1991 and is headquartered in Seattle, Washington. Cti Biopharm operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 121 people.
CTi Biopharma Stock Technical Analysis
CTi Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Did you try this?
Run Insider Screener Now
Insider ScreenerFind insiders across different sectors to evaluate their impact on performance |
All Next | Launch Module |
CTi Biopharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for CTi Biopharma's price direction in advance. Along with the technical and fundamental analysis of CTi Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of CTi to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0985 | |||
Jensen Alpha | 1.53 | |||
Total Risk Alpha | 0.7366 | |||
Sortino Ratio | 0.6253 | |||
Treynor Ratio | (6.76) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Consideration for investing in CTi Stock
If you are still planning to invest in CTi Biopharma Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CTi Biopharma's history and understand the potential risks before investing.
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Share Portfolio Track or share privately all of your investments from the convenience of any device |